- Home
- HUMA vs FMNB Comparison
HUMA vs FMNB Comparison
Compare HUMA & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- FMNB
- Stock Information
- Founded
- HUMA 2004
- FMNB 1887
- Country
- HUMA United States
- FMNB United States
- Employees
- HUMA N/A
- FMNB N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- FMNB Major Banks
- Sector
- HUMA Health Care
- FMNB Finance
- Exchange
- HUMA Nasdaq
- FMNB Nasdaq
- Market Cap
- HUMA 577.7M
- FMNB 574.7M
- IPO Year
- HUMA N/A
- FMNB N/A
- Fundamental
- Price
- HUMA $4.56
- FMNB $13.51
- Analyst Decision
- HUMA Strong Buy
- FMNB Hold
- Analyst Count
- HUMA 7
- FMNB 5
- Target Price
- HUMA $13.43
- FMNB $15.60
- AVG Volume (30 Days)
- HUMA 8.3M
- FMNB 91.8K
- Earning Date
- HUMA 11-08-2024
- FMNB 01-27-2025
- Dividend Yield
- HUMA N/A
- FMNB 5.04%
- EPS Growth
- HUMA N/A
- FMNB N/A
- EPS
- HUMA N/A
- FMNB 1.23
- Revenue
- HUMA N/A
- FMNB $162,960,000.00
- Revenue This Year
- HUMA N/A
- FMNB N/A
- Revenue Next Year
- HUMA $5,584.53
- FMNB $5.96
- P/E Ratio
- HUMA N/A
- FMNB $10.97
- Revenue Growth
- HUMA N/A
- FMNB N/A
- 52 Week Low
- HUMA $2.80
- FMNB $11.55
- 52 Week High
- HUMA $9.97
- FMNB $16.32
- Technical
- Relative Strength Index (RSI)
- HUMA 49.10
- FMNB 41.46
- Support Level
- HUMA $4.30
- FMNB $13.18
- Resistance Level
- HUMA $4.67
- FMNB $13.68
- Average True Range (ATR)
- HUMA 0.37
- FMNB 0.37
- MACD
- HUMA -0.04
- FMNB 0.02
- Stochastic Oscillator
- HUMA 36.99
- FMNB 47.03
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
About FMNB Farmers National Banc Corp.
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of company's revenue is derived from the bank segment.